BCM
DH icon

Blume Capital Management’s Definitive Healthcare DH Stock Holding History

Blume Capital Management’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$2K – 315
2022
Q1 		$2K Buy
+100
New +$2.26K ﹤0.01% 302

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SEM
Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Blume Capital Management's DH Position: Q2 2022 in Review

Blume Capital Management sold out of Definitive Healthcare (DH) in Q2 2022, closing a stake of 100 shares — an estimated $2K sold.

Blume Capital Management first reported a position in DH in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 116 funds tracked by Wall St. Rank hold DH as of Q2 2022.

  • Blume Capital Management reported no remaining Definitive Healthcare position as of Q2 2022 after selling out during the quarter.
  • Blume Capital Management sold 100 Definitive Healthcare shares in Q2 2022, an estimated $2K.
  • Blume Capital Management first reported a position in Definitive Healthcare in Q1 2022 and held it in 1 quarter.
  • Blume Capital Management's Definitive Healthcare position peaked at $2K in Q1 2022.
  • 116 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2022.

Based on Blume Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.